HomeOpen Access NewsInfectious Diseases

Infectious Diseases

New nasal vaccine could stop whooping cough spreading, trial finds

A NIHR-backed trial has found that BPZE1, a nasal spray vaccine, can block whooping cough bacteria from colonising the nose and throat.

How businesses can cope with the effects of Long Covid in the workplace

Gill Nye, Executive Head of HR at Cantium Business Solutions, explores the effect long covid will have on the workplace, with a particular focus on occupational health provision.

Are you eligible for the COVID-19 booster jab?

Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.

Third of leukaemia patients show no COVID-19 antibody response

According to a new study, a third of leukaemia patients fail to generate an antibody response following two COVID-19 vaccine doses.

Risk of pregnancy loss not associated with COVID-19 vaccines

According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.

What are zoonotic diseases?

Captain Casey Barton Behravesh of the U.S. Public Health Service, and Director of the CDC One Health Office highlights the CDC’s efforts to nationally and internationally prevent zoonotic diseases.

How will a changing climate affect the future of vector borne diseases?

With a changing climate, animal, insect, and plant species will either adapt or die under new environmental and climate conditions - this brings new challenges in the study of vector-borne infectious diseases.

Infection prevention and control – Lessons learned

Andrew Metcalfe, Director of Intelligent Infection Control Services Limited, LumiBio, explores the lessons learned in infection prevention and control.

COVID-19 vaccines: Risks versus benefits

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.

Impact of COVID-19 in African countries

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, offers preliminary context about the impact of the COVID-19 pandemic in most African countries, starting with lessons to be learned from previous outbreaks.

Optimising infection control post-pandemic

Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.

COVID-19: Antibody levels for the double-jabbed are waning

Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.

Double vaccination reduces risk of Long COVID by 49%

Double vaccinated adults are 49% less likely to have Long COVID if they were to contract COVID-19, according to a new study.

Five new research projects will examine COVID-19 vaccine responses

Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.

Clinical trial to test third COVID-19 vaccine for people with weakened immune systems

A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.

The risks of using alcohol-based hand sanitiser

Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the risks of using alcohol-based hand sanitiser.

Campaigners call for approval of life saving COVID-19 antibody treatments

A group of patient bodies, charities and senior clinicians have urged the Government to approve the use of life-saving COVID-19 antibody treatments.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders